Neurogastrx Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $45M
Latest Deal Amount
  • Investors
  • 3

Neurogastrx General Information

Description

Provider of biopharmaceutical research and development services designed to treat gastrointestinal disorders affecting the enteric nervous system. The company's biopharmaceutical services address unmet needs of functional and motility gastrointestinal disorders, enabling patients to get relief from bowel disorders

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 600 Unicorn Park Drive
  • Woburn, MA 01801
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurogastrx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 01-Aug-2018 $45M 000.00 000.00 Completed Generating Revenue
1. Seed Round 12-Sep-2016 00.000 00.000 000 Completed Generating Revenue
To view Neurogastrx’s complete valuation and funding history, request access »

Neurogastrx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Seed 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
To view Neurogastrx’s complete cap table history, request access »

Neurogastrx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of biopharmaceutical research and development services designed to treat gastrointestinal disorders affecting t
Drug Discovery
Woburn, MA
000.00
00.00 0000-00-00
00000000000 000.00

00000000

e cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cu
0000000000000
San Francisco, CA
0 As of 0000
0000
000000000 - 0000

00000000

d do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostr
000000000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neurogastrx Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OrphoMed Venture Capital-Backed San Francisco, CA 0 0000 000000000 - 0000
00000000 000000000 Corporate Backed or Acquired Cambridge, MA 000 00000 000000000 00000
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000&0
0000000 Formerly VC-backed Fremont, CA 00 00000 000000000 00000
00000 000000 Formerly VC-backed Solana Beach, CA 0 0000 00000000000 0000
You’re viewing 5 of 14 competitors. Get the full list »

Neurogastrx Executive Team (5)

Name Title Board Seat Contact Info
Jim O'Mara President, Chief Executive Officer and Board Member
Cyril De Colle Ph.D Co-Founder, Board Member & Chief Scientific Officer
Jeffrey Johnston MD Chief Medical Officer
To view Neurogastrx’s complete executive team members history, request access »

Neurogastrx Board Members (6)

Name Representing Role Since
Aaron Royston MD venBio Board Member 000 0000
David Allison Ph.D 5AM Ventures Board Member 000 0000
Kevin Koch Ph.D OrbiMed Board Member 000 0000
Klaus Veitinger Ph.D OrbiMed Chairman 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Neurogastrx Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
5AM Ventures Venture Capital Minority 000 0000 000000 0
OrbiMed PE/Buyout Minority 000 0000 000000 0
venBio Venture Capital Minority 000 0000 000000 0
To view Neurogastrx’s complete investors history, request access »